SCHEMBL6501940

SCHEMBL6501940

CCOC(=O)c1cc(COS(C)(=O)=O)nn1C1CCCCO1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 3/20 0.38
CYP4A11 Q02928 3/20 0.38
ALDH1A1 P00352 4/20 0.38
TSHR P16473 2/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
HSD17B10 Q99714 1/20 0.38
LMNA P02545 1/20 0.36
KMT2A Q03164 2/20 0.36
ATR Q13535 4/20 0.35
P2RY12 Q9H244 1/20 0.35
FAAH O00519 2/20 0.34
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C19 P33261 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6502231 0.86 CYP4F2 (0.39) CYP4F2CYP4A11ALDH1A1TSHRALOX15
SCHEMBL22826421 0.85 CYP4F2 (0.38) CYP4F2CYP4A11ALDH1A1TSHRALOX15
SCHEMBL14653527 0.83 CYP4F2 (0.42) CYP4F2CYP4A11ALDH1A1LMNAATR
SCHEMBL6502716 0.81 KMT2A (0.42) CYP4F2CYP4A11ALDH1A1TSHRALOX15
SCHEMBL24977637 0.78 TDP1 (0.38) CYP4F2CYP4A11ALDH1A1TSHRALOX15
SCHEMBL20382691 0.77 SMYD3 (0.38) CYP4F2CYP4A11ALDH1A1TSHRHSD17B10
SCHEMBL26638900 0.76 CYP4F2 (0.46) CYP4F2CYP4A11ALDH1A1TSHRALOX15
SCHEMBL20408354 0.75 KMT2A (0.40) CYP4F2CYP4A11ALDH1A1TSHRALOX15
SCHEMBL18587281 0.74 CYP4F2 (0.38) CYP4F2CYP4A11ALDH1A1HSD17B10LMNA
SCHEMBL26639009 0.74 ALDH1A1 (0.35) CYP4F2CYP4A11ALDH1A1TSHRALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050176775-A1 Substituted pyridinones PHARMACIA CORPORATION 2005-08-11 US disclosed
WO-2005018557-A2 SUBSTITUTED PYRIDINONES PHARMACIA CORPORATION (US) 2005-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176775-A1 Substituted pyridinones MAPK1, MAPK6, MAP3K6 CYP4F2 816/4885CYP4A11 880/4885ALDH1A1 741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.